NI201500078A - Composiciones que comprenden vortioxetina y donepezilo. - Google Patents
Composiciones que comprenden vortioxetina y donepezilo.Info
- Publication number
- NI201500078A NI201500078A NI201500078A NI201500078A NI201500078A NI 201500078 A NI201500078 A NI 201500078A NI 201500078 A NI201500078 A NI 201500078A NI 201500078 A NI201500078 A NI 201500078A NI 201500078 A NI201500078 A NI 201500078A
- Authority
- NI
- Nicaragua
- Prior art keywords
- vortioxetine
- donepezilo
- compositions including
- donepezil
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se proporcionan composiciones farmacéuticas que comprenden vortioxetina y donepezilo y el uso de una composición de este tipo para el tratamiento de disfunciones cognitivas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261736799P | 2012-12-13 | 2012-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201500078A true NI201500078A (es) | 2016-02-15 |
Family
ID=49943326
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201500078A NI201500078A (es) | 2012-12-13 | 2015-06-09 | Composiciones que comprenden vortioxetina y donepezilo. |
Country Status (44)
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105218482B (zh) * | 2014-06-24 | 2018-04-06 | 杭州和泽医药科技有限公司 | 沃替西汀氢溴酸盐β晶型的制备方法 |
| CN104610195B (zh) * | 2015-01-30 | 2017-06-27 | 上虞京新药业有限公司 | 沃替西汀的天冬氨酸盐或其水合物及其制备方法和用途 |
| CN105315184B (zh) * | 2015-06-26 | 2017-03-29 | 上海医药工业研究院 | 一种沃替西汀的制备方法及其中间体 |
| BR112018000841A8 (pt) * | 2015-07-17 | 2022-11-22 | Pasteur Institut | Agente estimulante de receptor 5-hidroxitriptamina1b para uso como um promotor de auto-renovação e/ou diferenciação de células satélites |
| CN105534933A (zh) * | 2016-01-19 | 2016-05-04 | 美吉斯制药（厦门）有限公司 | 一种沃替西汀口腔崩解片及其制备方法 |
| RU2018144248A (ru) | 2016-07-01 | 2020-08-03 | Х. Лундбекк А/С | Схемы дозирования вортиоксетина для быстрого появления антидепрессивного эффекта |
| US10398691B2 (en) | 2017-03-30 | 2019-09-03 | Rundle Research, LLC | Methods of treating depression |
| CA3048206C (en) * | 2017-03-30 | 2019-12-24 | Rundle Research, LLC | Transitioning patients from vortioxetine to a monoamine oxidase inhibitor |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0268871A1 (en) | 1986-10-31 | 1988-06-01 | Sumitomo Pharmaceuticals Company, Limited | Quinoline derivatives |
| WO1988008708A1 (en) | 1987-05-04 | 1988-11-17 | Bonnie Davis | Compounds for the treatment of alzheimer's disease |
| IT1225462B (it) | 1987-04-03 | 1990-11-14 | Mediolanum Farmaceutici Srl | Sali organici di derivati della fisostigmina |
| EP0403713A1 (en) | 1989-06-22 | 1990-12-27 | Merrell Dow Pharmaceuticals Inc. | Novel acetylcholinesterase inhibitors |
| US4914102A (en) | 1989-09-28 | 1990-04-03 | Hoechst Roussel Pharmaceuticals, Inc. | N-aminocarbamates related to physostigmine, pharmacentical compositions and use |
| TW200462B (es) | 1990-09-27 | 1993-02-21 | Hoechst Roussel Pharma | |
| US5246947A (en) | 1991-09-23 | 1993-09-21 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted pyridinylamino-1,2-benzisothiazoles and their use for treating depression |
| US5231093A (en) | 1991-10-01 | 1993-07-27 | Hoechst-Roussel Pharmaceuticals Incorporated | Carbamate derivatives of 4-amino-3-isoxazolidinones, 3-amino-1-hydroxypyrrolidin-2-ones and 1-amino-1-cyclopropanecarboxylic acid analogs |
| ES2042384B1 (es) | 1991-12-26 | 1994-06-01 | Boehringer Ingelheim Espana | Procedimiento para obtener derivados bis-piridinicos. |
| SE9302080D0 (sv) | 1993-06-16 | 1993-06-16 | Ab Astra | New compounds |
| DK0892796T3 (da) | 1996-04-12 | 2001-11-19 | Aventis Pharma Inc | Isatinderivater som acetylcholinesteraseinhibitorer og analgetika |
| UA81749C2 (uk) | 2001-10-04 | 2008-02-11 | Х. Луннбек А/С | Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну |
| WO2003082820A1 (fr) | 2002-03-29 | 2003-10-09 | Eisai Co., Ltd. | Derive de (1-indanone)-(1,2,3,6-tetrahydropyridine) |
| JP2005528431A (ja) * | 2002-05-31 | 2005-09-22 | ハー・ルンドベック・アクチエゼルスカベット | アルツハイマー病を治療するためのｎｍｄａ−アンタゴニスト及びアセチルコリンエステラーゼ阻害剤の組み合わせ物 |
| WO2004058258A1 (en) * | 2002-12-24 | 2004-07-15 | Neurochem (International) Limited | Therapeutic formulations for the treatment of beta-amyloid related diseases |
| BRPI0621655A2 (pt) * | 2006-05-08 | 2011-12-20 | Teikoku Seiyaku Kk | preparação para a absorção percutánea de uma droga antidemência básica |
| CA2649576A1 (en) * | 2006-06-09 | 2007-12-21 | Wyeth | Method for enhancing cognitive function |
| PT2044043E (pt) | 2006-06-16 | 2012-03-26 | Lundbeck & Co As H | 1-[2-(2,4-dimetilfenilsulfanil)fenil]piperazina como um composto que combina a reabsorção de serotonina, à actividade de 5-ht3 e 5-ht1a para o tratamento de perturbação congnitiva |
| WO2009005519A1 (en) * | 2007-06-29 | 2009-01-08 | Accera, Inc. | Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism |
| TW200932233A (en) * | 2007-11-13 | 2009-08-01 | Lundbeck & Co As H | Therapeutic uses of compounds having combined SERT, 5-HT3 and 5-HT1a activity |
| TW201033181A (en) | 2009-02-17 | 2010-09-16 | Lundbeck & Co As H | Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine |
-
2013
- 2013-12-12 GE GEAP201313850A patent/GEP201706739B/en unknown
- 2013-12-12 HU HUE13818702A patent/HUE036280T2/hu unknown
- 2013-12-12 SG SG11201504483YA patent/SG11201504483YA/en unknown
- 2013-12-12 ME MEP-2018-66A patent/ME03029B/me unknown
- 2013-12-12 KR KR1020157015715A patent/KR102171152B1/ko active IP Right Grant
- 2013-12-12 US US14/649,087 patent/US9211288B2/en active Active
- 2013-12-12 MX MX2015007269A patent/MX362886B/es active IP Right Grant
- 2013-12-12 CA CA2893468A patent/CA2893468C/en active Active
- 2013-12-12 AR ARP130104651A patent/AR093939A1/es not_active Application Discontinuation
- 2013-12-12 MA MA38253A patent/MA38253B1/fr unknown
- 2013-12-12 DK DK13818702.6T patent/DK2931276T3/en active
- 2013-12-12 PT PT138187026T patent/PT2931276T/pt unknown
- 2013-12-12 UA UAA201506381A patent/UA114016C2/uk unknown
- 2013-12-12 ES ES13818702.6T patent/ES2663680T3/es active Active
- 2013-12-12 MY MYPI2015001479A patent/MY171802A/en unknown
- 2013-12-12 SI SI201330970T patent/SI2931276T1/en unknown
- 2013-12-12 EA EA201590932A patent/EA028300B1/ru not_active IP Right Cessation
- 2013-12-12 JP JP2015547020A patent/JP6257641B2/ja active Active
- 2013-12-12 PL PL13818702T patent/PL2931276T3/pl unknown
- 2013-12-12 PE PE2015000879A patent/PE20151026A1/es active IP Right Grant
- 2013-12-12 AU AU2013357308A patent/AU2013357308B2/en not_active Ceased
- 2013-12-12 LT LTEP13818702.6T patent/LT2931276T/lt unknown
- 2013-12-12 WO PCT/EP2013/076337 patent/WO2014090929A1/en active Application Filing
- 2013-12-12 NZ NZ708595A patent/NZ708595A/en not_active IP Right Cessation
- 2013-12-12 CN CN201380065034.2A patent/CN104853755B/zh active Active
- 2013-12-12 AP AP2015008498A patent/AP2015008498A0/xx unknown
- 2013-12-12 EP EP13818702.6A patent/EP2931276B1/en active Active
- 2013-12-12 BR BR112015013675-3A patent/BR112015013675B1/pt not_active IP Right Cessation
- 2013-12-12 RS RS20180285A patent/RS56949B1/sr unknown
- 2013-12-12 RU RU2015122256A patent/RU2635528C2/ru active
-
2014
- 2014-03-05 NO NO14709546A patent/NO2970700T3/no unknown
-
2015
- 2015-05-27 TN TNP2015000235A patent/TN2015000235A1/fr unknown
- 2015-06-03 DO DO2015000133A patent/DOP2015000133A/es unknown
- 2015-06-03 IL IL239192A patent/IL239192B/en active IP Right Grant
- 2015-06-08 PH PH12015501302A patent/PH12015501302B1/en unknown
- 2015-06-08 GT GT201500143A patent/GT201500143A/es unknown
- 2015-06-09 NI NI201500078A patent/NI201500078A/es unknown
- 2015-06-09 CR CR20150303A patent/CR20150303A/es unknown
- 2015-06-09 EC ECIEPI201523182A patent/ECSP15023182A/es unknown
- 2015-06-10 CL CL2015001615A patent/CL2015001615A1/es unknown
- 2015-06-12 ZA ZA2015/04274A patent/ZA201504274B/en unknown
-
2016
- 2016-01-18 HK HK16100513.0A patent/HK1212601A1/zh unknown
-
2018
- 2018-02-23 HR HRP20180333TT patent/HRP20180333T1/hr unknown
- 2018-03-27 CY CY20181100347T patent/CY1120098T1/el unknown
-
2022
- 2022-05-19 AR ARP220101337A patent/AR125920A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201500078A (es) | Composiciones que comprenden vortioxetina y donepezilo. | |
| CL2014001829A1 (es) | Compuestos derivados de indolizina; procedimiento de preparación; composiciones farmacéuticas que los contienen y uso en el tratamiento del cancer. | |
| CL2013003019A1 (es) | Compuestos derivados de benzotiazol; composicion farmaceutica que los comprende; y su uso en el tratamiento del vih. | |
| CL2015001731A1 (es) | Compuestos inhibidores de autotaxina; composicion y combinacion farmaceutica; y uso en el tratamiento de enfermedades tales como fibrosis, prurito, cancer, entre otras. | |
| CL2014003136A1 (es) | Nuevos diazaespirocicloalcanos y azaespirocicloalcanos; composicion farmaceutica que los contiene y usos. | |
| CL2013002898A1 (es) | Compuestos derivados de benceno sustituido con arilo o heteroarilo; composicion farmaceutica que los comprende y uso en el tratamiento del cancer. | |
| CL2016000153A1 (es) | Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b | |
| CL2014002093A1 (es) | Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas. | |
| CL2016002877A1 (es) | Compuestos de 2-cloro-2-difluorometoxifenil pirazolopirimidina, composiciones y métodos de uso de los mismos. | |
| CL2015000942A1 (es) | Compuestos de benceno sustituido. | |
| CL2012003415A1 (es) | Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer . | |
| CL2014001865A1 (es) | Compuestos derivados de fosfatos; procedimiento de preparacion; composiciones farmaceuticas que los contienen y uso en el tratamiento del cancer. | |
| UY34220A (es) | Indazoles, composiciones farmacéuticas y uso de los mismos | |
| CL2015000976A1 (es) | Compuestos de 2-fenil-5-heterociclil-tetrahidro-2h-piran-3-amina para uso en el tratamiento de diabetes y sus trastornos asociados. | |
| CL2015001202A1 (es) | Compuestos derivados de oxazolidin-2-ona-pirimidina; composicion y combinacion farmaceutica y uso en el tratamiento del cancer. | |
| CL2012003322A1 (es) | Compuestos derivados de benzamida sustituidas; composicion farmacéutica; y uso en el tratamiento del cancer. | |
| SV2015005126A (es) | Nuevos compuestos para el tratamiento del cáncer | |
| CL2014003525A1 (es) | Composicion farmaceutica que comprende fimasartan, hidroclorotiazida y un aglutinante; procedimiento de preparacion; su uso en el tratamiento de hipertension. | |
| DOP2017000058A (es) | Derivados de tetrahidroquinolina como inhibidores del bromodominio | |
| CL2013003625A1 (es) | Compuestos derivados de tetrahidroquinolinas condensadas con un cicloalquilo; formulacion farmaceutica que los comprende; y uso como moduladores de receptores de crth2 en el tratamiento del asma, rinitis alergica o epoc. | |
| CL2014001862A1 (es) | Compuestos derivados de morofolinilo sustituido, útiles como inhibidores de mogat-2; composicion farmaceutica que los comprende; uso en el tratamiento de hipertrigliceridemia. | |
| BR112014026397A2 (pt) | composição e uso de uma composição | |
| UY34829A (es) | Nueva dosificación y formulación | |
| CL2012003265A1 (es) | Polisacarido de semillas de tamarindo para usarse en el tratamiento de enfermedades infecciosas; composicion farmacéutica y/o dermocosmética antiinflamatoria que contiene dicho polisacárido; uso de un polisacárido de semilla de tamarindo. | |
| BR112014025416A2 (pt) | AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS. |